Form 4: Zeo ScientifiX Director Glauser Receives Stock Options

Director Steven Jerry Glauser reports the acquisition of stock options in Zeo ScientifiX, Inc.

Summary

• Steven Jerry Glauser, a director of Zeo ScientifiX, Inc., filed a Form 4 on May 12, 2025.
• The filing reports the grant of stock options to Glauser on May 8, 2025.
• Two grants of stock options were made, each for 5,000 shares of common stock, under the company's 2021 Equity Incentive Plan.
• The exercise price for both sets of options is $2.86.
• One set of 5,000 options vested fully on the grant date, May 8, 2025, and expires on May 8, 2030.
• The other set of 5,000 options had 2,000 shares vest on the grant date, with the remaining 3,000 shares vesting on September 23, 2025, and expires on May 8, 2030.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock option grants, which is neither inherently positive nor negative. The sentiment is neutral.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule for one of the grants incentivizes continued service by the director.

Industry Context

Stock option grants are a common form of executive compensation in many industries, particularly in technology and growth-oriented companies. They are used to attract and retain talent, and to align the interests of management with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies.
• The vesting schedules and exercise prices are typically determined based on industry benchmarks and company-specific performance metrics.
• Companies like Tesla, Apple, and Microsoft also use stock options as part of their compensation strategy.

Stakeholder Impact

• The stock option grants may have a minor dilutive effect on existing shareholders.
• The grants incentivize the director to work towards increasing shareholder value.

Key Dates

Keywords

stock options, Form 4, director, ZEOX, Zeo ScientifiX, insider trading